window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date());gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : September 15, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

RBQM

  • Clinical & Regulatory,Digital & Data,Research & Development

    CluePoints brings AI-powered clinical data review to DPHARM 2026

    AI and Robust Scientific Foundations to Optimize Clinical Trial Operations [...]

    September 14, 2026
  • Clinical & Regulatory,Digital & Data,Research & Development

    Study quantifies financial benefits of risk-based quality management in oncology trials

    A peer-reviewed study published in Therapeutic Innovation & Regulatory Science [...]

    July 8, 2026
  • Clinical & Regulatory,Digital & Data

    Transitioning to risk-based clinical trial management under ICH E6(R3)

    Risk-based quality management (RBQM) is becoming central to clinical trial [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Pharmaceuticals and therapeutics

    CluePoints names Sinead Godkin CPO to scale global workforce

    CluePoints has appointed Sinead Godkin as chief people officer, strengthening [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    CluePoints: how proactive oversight and AI are reshaping clinical trial data management

    Dan Beaudry, market owner for risk-based quality management (RBQM) at [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data

    Six geese a-laying: CluePoints’ AI predictions for 2026

    As our Christmas countdown continues, we move from reflections on [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    Today Discover Pharma launches its annual 12 Days of Christmas campaign featuring CluePoints insight on RBQM

    The launch of the 12 Days of Christmas campaign marks [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    OptymEdge appoints senior director to lead global roll-out of ACUVERA platform

    OptymEdge has appointed Amy Del Medico as senior director of [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Delivery & Formulation,Drug Discovery & Development

    eClinical Solutions adds integrated data review plan capabilities to elluminate platform

    Company becomes the first to centralize digital data review activities [...]

    May 5, 2026
  • Manufacturing & Supply Chain

    Building resilient pharma supply chains amid increasing tariff volatility

    Amid escalating trade tensions and regulatory complexity, pharma manufacturers are [...]

    May 5, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Isomab data support safety of angiogenic approaches in coronary artery disease
    Categories: Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • FDA approves Tivicay PD for children with HIV weighing at least 2kg
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Tezspire meets Phase 3 endpoints in eosinophilic esophagitis
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top